192 related articles for article (PubMed ID: 12816714)
21. [Optimal cut-off value of PIVKA-II for diagnosis of hepatocellular carcinoma--using ROC curve].
Kim MJ; Bae KW; Seo PJ; Jeong IK; Kim JH; Lee BH; Bang KT; Kim DW; Song IH
Korean J Hepatol; 2006 Sep; 12(3):404-11. PubMed ID: 16998292
[TBL] [Abstract][Full Text] [Related]
22. [Clinical evaluation of several tumor markers in the diagnosis of primary hepatic cancer].
Shi X; Zhou Y; Xia L
Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):437-9. PubMed ID: 10920938
[TBL] [Abstract][Full Text] [Related]
23. Detection of serum alpha-fetoprotein in dogs with hepatic tumors.
Lowseth LA; Gillett NA; Chang IY; Muggenburg BA; Boecker BB
J Am Vet Med Assoc; 1991 Sep; 199(6):735-41. PubMed ID: 1720115
[TBL] [Abstract][Full Text] [Related]
24. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
[TBL] [Abstract][Full Text] [Related]
25. [Serum concentrations of alpha-1-fetoprotein suggestive of, or pathognomonic for hepatoma (author's transl)].
Polterauer P; Horak W; Legenstein E; Müller M
Wien Klin Wochenschr; 1979 Mar; 91(6):201-4. PubMed ID: 85372
[TBL] [Abstract][Full Text] [Related]
26. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
[TBL] [Abstract][Full Text] [Related]
27. [Preparation of time-resolved fluoroimmunoassay kit for human alpha-fetoprotein detection].
Hang JF; Wu YS; Yu WH; Xu WW; Wang CR; Qiu YR; Li M
Di Yi Jun Yi Da Xue Xue Bao; 2005 Mar; 25(3):313-7. PubMed ID: 15772001
[TBL] [Abstract][Full Text] [Related]
28. [Significance of Golgi glycoprotein 73, a new tumor marker in diagnosis of hepatocellular carcinoma: a primary study].
Mao YL; Yang HY; Xu HF; Sang XT; Lu X; Yang ZY; Zhang JC; Zhong SX; Huang JF; Zhang HB
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):948-51. PubMed ID: 18756964
[TBL] [Abstract][Full Text] [Related]
29. The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance.
Huo TI; Hsia CY; Chu CJ; Huang YH; Lui WY; Wu JC; Lee PC; Chi CW; Lee SD
J Surg Oncol; 2007 Jun; 95(8):645-51. PubMed ID: 17530668
[TBL] [Abstract][Full Text] [Related]
30. Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications.
Debruyne EN; Delanghe JR
Clin Chim Acta; 2008 Sep; 395(1-2):19-26. PubMed ID: 18538135
[TBL] [Abstract][Full Text] [Related]
31. Tumour-specific induction of immune complexes: DCP-IgM in hepatocellular carcinoma.
Beneduce L; Pesce G; Gallotta A; Zampieri F; Biasiolo A; Tono N; Boscato N; Gatta A; Pontisso P; Fassina G
Eur J Clin Invest; 2008 Aug; 38(8):571-7. PubMed ID: 18625005
[TBL] [Abstract][Full Text] [Related]
32. Serological markers of liver cancer.
Yuen MF; Lai CL
Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):91-9. PubMed ID: 15757806
[TBL] [Abstract][Full Text] [Related]
33. [Screening for hepatocellular carcinoma].
Leone N; Rizzetto M
Minerva Med; 2005 Apr; 96(2):95-108. PubMed ID: 16172579
[TBL] [Abstract][Full Text] [Related]
34. Clinical characteristics among patients with hepatocellular carcinoma according to the serum levels of alpha-fetoprotein and des-y-carboxy prothrombin.
Dohmen K; Shigematsu H; Irie K; Ishibashi H
Hepatogastroenterology; 2003; 50(54):2072-8. PubMed ID: 14696467
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B surface antigenaemia and alpha-foetoprotein detection from dried blood spots: applications to field-based studies and to clinical care in hepatitis B virus endemic areas.
Mendy M; Kirk GD; van der Sande M; Jeng-Barry A; Lesi OA; Hainaut P; Sam O; McConkey S; Whittle H
J Viral Hepat; 2005 Nov; 12(6):642-7. PubMed ID: 16255766
[TBL] [Abstract][Full Text] [Related]
36. Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma.
Sterling RK; Jeffers L; Gordon F; Venook AP; Reddy KR; Satomura S; Kanke F; Schwartz ME; Sherman M
Clin Gastroenterol Hepatol; 2009 Jan; 7(1):104-13. PubMed ID: 18849011
[TBL] [Abstract][Full Text] [Related]
37. Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patients.
Giannelli G; Fransvea E; Trerotoli P; Beaugrand M; Marinosci F; Lupo L; Nkontchou G; Dentico P; Antonaci S
Clin Chim Acta; 2007 Aug; 383(1-2):147-52. PubMed ID: 17582392
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma.
Hu KQ; Kyulo NL; Lim N; Elhazin B; Hillebrand DJ; Bock T
Am J Gastroenterol; 2004 May; 99(5):860-5. PubMed ID: 15128351
[TBL] [Abstract][Full Text] [Related]
39. Serum alpha-fetoprotein response as a surrogate for clinical outcome in patients receiving systemic therapy for advanced hepatocellular carcinoma.
Vora SR; Zheng H; Stadler ZK; Fuchs CS; Zhu AX
Oncologist; 2009 Jul; 14(7):717-25. PubMed ID: 19581525
[TBL] [Abstract][Full Text] [Related]
40. Preliminary study on the clinical and pathological relevance of gastric hepatoid adenocarcinoma.
Gao YB; Zhang DF; Jin XL; Xiao JC
J Dig Dis; 2007 Feb; 8(1):23-8. PubMed ID: 17261131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]